Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis
JAMA
.
2021 Oct 19;326(15):1535.
doi: 10.1001/jama.2021.13863.
Authors
Kunal Chandwar
1
,
Puneet Kumar
1
,
Urmila Dhakad
1
Affiliation
1
Department of Clinical Immunology and Rheumatology, King George's Medical University, Lucknow, Uttar Pradesh, India.
PMID:
34665210
DOI:
10.1001/jama.2021.13863
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / drug therapy
Glucocorticoids*
Humans
Remission Induction
Rituximab
Substances
Glucocorticoids
Rituximab